NO143669C - Fremgangsmaate ved fremstilling av lasalocidantibiotika - Google Patents

Fremgangsmaate ved fremstilling av lasalocidantibiotika

Info

Publication number
NO143669C
NO143669C NO751097A NO751097A NO143669C NO 143669 C NO143669 C NO 143669C NO 751097 A NO751097 A NO 751097A NO 751097 A NO751097 A NO 751097A NO 143669 C NO143669 C NO 143669C
Authority
NO
Norway
Prior art keywords
lasalocid
antibiotics
procedure
preparation
lasalocid antibiotics
Prior art date
Application number
NO751097A
Other languages
English (en)
Other versions
NO143669B (no
NO751097L (no
Inventor
John Westley
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO751097L publication Critical patent/NO751097L/no
Publication of NO143669B publication Critical patent/NO143669B/no
Publication of NO143669C publication Critical patent/NO143669C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/40Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/04Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465Streptomyces

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO751097A 1974-04-02 1975-04-01 Fremgangsmaate ved fremstilling av lasalocidantibiotika NO143669C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45729674A 1974-04-02 1974-04-02

Publications (3)

Publication Number Publication Date
NO751097L NO751097L (no) 1975-10-03
NO143669B NO143669B (no) 1980-12-15
NO143669C true NO143669C (no) 1981-03-25

Family

ID=23816176

Family Applications (1)

Application Number Title Priority Date Filing Date
NO751097A NO143669C (no) 1974-04-02 1975-04-01 Fremgangsmaate ved fremstilling av lasalocidantibiotika

Country Status (12)

Country Link
AR (1) AR213070A1 (no)
DD (1) DD117474A5 (no)
DK (1) DK141582B (no)
ES (1) ES436177A1 (no)
FI (1) FI56979C (no)
IE (1) IE40896B1 (no)
IL (1) IL46971A (no)
NO (1) NO143669C (no)
NZ (1) NZ177066A (no)
PH (1) PH12815A (no)
SE (1) SE7503716L (no)
ZA (1) ZA751801B (no)

Also Published As

Publication number Publication date
ES436177A1 (es) 1977-04-01
DK141582B (da) 1980-04-28
FI56979C (fi) 1980-05-12
SE7503716L (no) 1975-10-03
FI56979B (fi) 1980-01-31
DD117474A5 (no) 1976-01-12
IL46971A0 (en) 1975-05-22
NO143669B (no) 1980-12-15
NZ177066A (en) 1978-09-20
AR213070A1 (es) 1978-12-15
NO751097L (no) 1975-10-03
ZA751801B (en) 1976-02-25
IE40896L (en) 1975-10-02
FI750980A (no) 1975-10-03
PH12815A (en) 1979-08-28
DK137675A (no) 1975-10-03
DK141582C (no) 1980-10-06
IE40896B1 (en) 1979-09-12
IL46971A (en) 1978-03-10

Similar Documents

Publication Publication Date Title
NO143940C (no) Fremgangsmaate ved fremstilling av alfa-l-aspartyl-l-fenyl-alaninalkylestere
SE7505040L (sv) Forfarande for framstellning av n-fosfonometylglycin.
NO145247C (no) Fremgangsmaate for fremstilling av clavulansyre
NO142196C (no) Fremgangsmaate for fremstilling av avfarvede kaldtvannsopploeselige tegarvestoffer
SE7513085L (sv) Forfarande for framstellning av etrar
NO142894C (no) Fremgangsmaate ved fremstilling av polyethylenterefthalatfilm
SE7506160L (sv) Forfarande for framstellning av n-cykloalkylmetyldekahydroisokinoline
SE409452B (sv) Forfarande for framstellning av stilbenderivat
SE7506237L (sv) Forfarande for framstellning av dekahydroisokinolinderivat
SE7900773L (sv) Nytt forfarande for framstellning av foreningen amoxycillin
SE411453B (sv) Forfarande for framstellning av 3-fluorcefalosporiner
SE403477B (sv) Forfarande for famstellning av substituerade indoleniner
NO146141C (no) Fremgangsmaate til fremstilling av aminocyklitolantibiotika
SE7513739L (sv) Forfarande for framstellning av 2-scyl-4-oxo-pyrazino-isokonolin-derivat
SE7511801L (sv) Forfarande for framstellning av ympsampolymerisat
SE388854B (sv) Forfarande for framstellning av fenylpyridylaminderivat
SE7506196L (sv) Forfarande for framstellning av amidin-hydrazon-derivat
SE7505751L (sv) Forfarande for framstellning av cefalosporiner
NO140297C (no) Fremgangsmaate ved fremstilling av alfa1-t-butylaminomethyl-4-hydroxy-m-xylen-alfa1,alfa3-diol
SE7508844L (sv) Forfarande for framstellning av cefalosporiner.
SE7701667L (sv) Forfarande for framstellning av cefalosporin-antibiotika
NO143224C (no) Fremgangsmaate ved fremstilling av hydroxyalkylxanthiner
SE423815B (sv) Forfarande for framstellning av aminometylarylmetylpenicilliner
SE422679B (sv) Forfarande for framstellning av etynylbensenforeningar
NO143669C (no) Fremgangsmaate ved fremstilling av lasalocidantibiotika